Literature DB >> 25597559

Underuse of oral anticoagulation for individuals with atrial fibrillation in a nursing home setting in France: comparisons of resident characteristics and physician attitude.

Oarda Bahri1, Frederic Roca, Tarik Lechani, Laurent Druesne, Pierre Jouanny, Jean-Marie Serot, Eric Boulanger, Francois Puisieux, Philippe Chassagne.   

Abstract

OBJECTIVES: To describe the characteristics of nursing home residents diagnosed with atrial fibrillation (AF) and eligible for oral anticoagulants who did not receive these drugs and to detail the conditions that physicians who decide not to prescribe anticoagulants take into account.
DESIGN: Cross-sectional.
SETTING: Nursing home. PARTICIPANTS: Nursing home residents with a history of AF (N = 1,085). MEASUREMENTS: Data were collected on clinical characteristics, geriatric syndromes, and antithrombotic regimen. Multivariate logistic regression was used to identify factors associated with nonprescription of anticoagulants. A standardized questionnaire was submitted to physicians in charge of patients with AF, to detail conditions associated with their medical decision not to prescribe anticoagulants.
RESULTS: History of AF was present in 1,085 nursing home residents (10.1%), mean age 87, with a mean CHA2DS2-VASc score of 5.1 ± 1.4. Of these residents with AF, 544 (50.1%) did not receive anticoagulants. Recurrent falls (odds ratio (OR) = 4.9, 95% confidence interval (CI) = 2.4-9.9, P < .001), past history of bleeding (OR = 3.62, 95% CI = 1.54-8.51, P = .003), paroxysmal AF (OR = 3.5, 95% CI = 1.83-6.66, P < .001), and advanced age (OR = 1.1, 95% CI = 1.01-1.17, P = .02) were significantly associated with not prescribing anticoagulants. Recurrent falls (47%), cognitive impairment (22.6%), and advanced age (16.4%) were the main reasons for not prescribing anticoagulants.
CONCLUSION: The prevalence of AF in a cohort of very old nursing home residents was 10%. Anticoagulation was prescribed in fewer than 50% of eligible cases despite high individual risk of stroke. Geriatric syndromes, especially falls and cognitive disorders, were the main reported contraindications for prescribing anticoagulants. Physicians caring for those residents wrongly thought that paroxysmal AF caused fewer thromboembolic events than permanent AF, which explains lower rates of anticoagulant prescription in individuals with paroxysmal AF.
© 2015, Copyright the Authors Journal compilation © 2015, The American Geriatrics Society.

Entities:  

Keywords:  anticoagulation; atrial fibrillation; nursing home

Mesh:

Substances:

Year:  2015        PMID: 25597559     DOI: 10.1111/jgs.13200

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  30 in total

1.  The role of contraindications in prescribing anticoagulants to patients with atrial fibrillation: a cross-sectional analysis of primary care data in the UK.

Authors:  Nicola Adderley; Ronan Ryan; Tom Marshall
Journal:  Br J Gen Pract       Date:  2017-06-19       Impact factor: 5.386

2.  Underuse of Oral Anticoagulants and Inappropriate Prescription of Antiplatelet Therapy in Older Inpatients with Atrial Fibrillation.

Authors:  Lorette Averlant; Grégoire Ficheur; Laurie Ferret; Stéphane Boulé; François Puisieux; Michel Luyckx; Julien Soula; Alexandre Georges; Régis Beuscart; Emmanuel Chazard; Jean-Baptiste Beuscart
Journal:  Drugs Aging       Date:  2017-09       Impact factor: 3.923

3.  [Falls and dementia are not contraindications for anticoagulation in older adults with atrial fibrillation].

Authors:  M Gosch; B Iglseder; H J Heppner
Journal:  Z Gerontol Geriatr       Date:  2016-07       Impact factor: 1.281

4.  Geriatric Elements and Oral Anticoagulant Prescribing in Older Atrial Fibrillation Patients: SAGE-AF.

Authors:  Jane S Saczynski; Saket R Sanghai; Catarina I Kiefe; Darleen Lessard; Francesca Marino; Molly E Waring; David Parish; Robert Helm; Felix Sogade; Robert Goldberg; Jerry Gurwitz; Weijia Wang; Tanya Mailhot; Benita Bamgbade; Bruce Barton; David D McManus
Journal:  J Am Geriatr Soc       Date:  2019-10-01       Impact factor: 5.562

5.  Effect of New Oral Anticoagulants on Prescribing Practices for Atrial Fibrillation in Older Adults.

Authors:  Raymond B Fohtung; Eric Novak; Michael W Rich
Journal:  J Am Geriatr Soc       Date:  2017-08-21       Impact factor: 5.562

6.  Physician decision making in anticoagulating atrial fibrillation: a prospective survey of a physician notification system for atrial fibrillation detected on cardiac implantable electronic devices of patients at increased risk of stroke.

Authors:  Justin M Cloutier; Clarence Khoo; Brett Hiebert; Anthony Wassef; Colette M Seifer
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-04

Review 7.  Stroke prevention strategies in high-risk patients with atrial fibrillation.

Authors:  Agnieszka Kotalczyk; Michał Mazurek; Zbigniew Kalarus; Tatjana S Potpara; Gregory Y H Lip
Journal:  Nat Rev Cardiol       Date:  2020-10-27       Impact factor: 32.419

8.  Impact of Fall Risk and Direct Oral Anticoagulant Treatment on Quality-Adjusted Life-Years in Older Adults with Atrial Fibrillation: A Markov Decision Analysis.

Authors:  Wenfei Wei; Rafia S Rasu; José J Hernández-Muñoz; Renee J Flores; Nahid J Rianon; Genesis A Hernández-Vizcarrondo; Adam T Brown
Journal:  Drugs Aging       Date:  2021-07-08       Impact factor: 3.923

9.  Oral anticoagulation in patients with atrial fibrillation and medical non-neoplastic disease in a terminal stage.

Authors:  Jesús Díez-Manglano; Máximo Bernabeu-Wittel; José Murcia-Zaragoza; Belén Escolano-Fernández; Guadalupe Jarava-Rol; Carlos Hernández-Quiles; Miguel Oliver; Susana Sanz-Baena
Journal:  Intern Emerg Med       Date:  2016-08-11       Impact factor: 3.397

Review 10.  What is the Impact of Frailty on Prescription of Anticoagulation in Elderly Patients with Atrial Fibrillation? A Systematic Review and Meta-Analysis.

Authors:  Zardasht Oqab; Payam Pournazari; Robert S Sheldon
Journal:  J Atr Fibrillation       Date:  2018-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.